Patent details

EP3600326 Title: DOSE AND REGIMEN FOR AN HDM2-P53 INTERACTION INHIBITOR IN HEMATOLOGICAL TUMORS

Basic Information

Publication number:
EP3600326
PCT Application Number:
IB2018052187
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP187189261
PCT Publication Number:
WO2018178925
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
DOSE AND REGIMEN FOR AN HDM2-P53 INTERACTION INHIBITOR IN HEMATOLOGICAL TUMORS
French Title of Invention:
DOSE ET RÉGIME POSOLOGIQUE POUR UN INHIBITEUR D'INTERACTION HDM2-P53 DANS DES TUMEURS HÉMATOLOGIQUES
German Title of Invention:
DOSIS UND DOSIERSCHEMA FÜR EINEN HDM2-P53-WECHSELWIRKUNGSHEMMER BEI HÄMATOLOGISCHEN TUMOREN
SPC Number:

Dates

Filing date:
29/03/2018
Grant date:
25/01/2023
EP Publication Date:
05/02/2020
PCT Publication Date:
04/10/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/01/2023
EP B1 Publication Date:
25/01/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
29/03/2023
Expiration date:
29/03/2038
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/01/2023
 
 

Name:
Novartis AG
Address:
Lichtstrasse 35, 4056 Basel, Switzerland (CH)

Inventor

1

Name:
FABRE, Claire
Address:
Switzerland (CH)

2

Name:
WUERTHNER, Jens
Address:
Switzerland (CH)

3

Name:
MEILLE, Christophe
Address:
Switzerland (CH)

4

Name:
JEAY, Sebastien
Address:
Switzerland (CH)

5

Name:
GUERREIRO, Nelson
Address:
Switzerland (CH)

6

Name:
FERRETTI, Stephane
Address:
Switzerland (CH)

7

Name:
JULLION, Astrid
Address:
Switzerland (CH)

Priority

Priority Number:
201762479397 P
Priority Date:
31/03/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/506; A61K 45/06; A61P 35/02;

Publication

European Patent Bulletin

Issue number:
202304
Publication date:
25/01/2023
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages